相关实验视频
Updated: Jun 18, 2025

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.5K
评估他类药物治疗在膀癌中的作用:来自孟德尔随机化研究的证据
Rongkang Li1,2,3, Guixiao Huang2, Yunfei Li2
1Institute of Urology, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China.
Frontiers in pharmacology
|August 5, 2024
概括
根据孟德尔随机化 (MR) 分析,使用罗斯瓦斯塔丁可能会因果性地降低膀癌症风险. 在这项研究中,阿托瓦斯塔丁和西姆瓦斯塔丁与膀癌症风险没有显著关联.
科学领域:
- 药物基因组学 药物基因组学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 类药物是用于预防心血管疾病的广泛处方的降脂药物.
- 新兴研究表明,他类药物在预防癌症方面可能发挥作用.
- 类他类药物使用和膀癌之间的因果关系仍然不确定.
研究的目的:
- 调查他类药物治疗对膀癌风险的潜在因果作用.
- 分析阿托瓦斯塔丁,西姆瓦斯塔丁和罗斯瓦斯塔丁与膀癌的特定关联.
- 为了利用孟德尔随机化 (MR) 进行强大的因果推理.
主要方法:
- 采用了两样本的门德尔随机化 (MR) 研究设计.
- 利用来自大型全基因组关联研究 (GWAS) 的遗传数据.
- 分析了来自英国生物库 (他类药物使用) 和欧洲队列 (膀癌) 的总结级数据.
主要成果:
- 罗斯瓦斯塔丁的使用与膀癌风险有显著的反向因果关系 (OR = 3.52E-19,p = 0.005).
- 阿托瓦斯塔丁和西姆瓦斯塔丁没有证明与膀癌风险的统计学上显著的因果关系.
- 进行了敏感性分析,以确保研究结果的可靠性.
结论:
- 基因预测的罗斯瓦斯塔丁使用与膀癌的风险降低有关.
- 对于阿托瓦斯塔丁或西姆瓦斯塔丁在膀癌上没有发现显著的遗传预测因果作用.
- 这些发现有助于理解他类药物与癌症风险之间的复杂相互作用.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
610
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
610
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

